nucleic
acid
carri
build
plan
live
system
exploit
make
cell
produc
desir
protein
shut
express
endogen
gene
even
repair
defect
gene
henc
nucleic
acid
uniqu
substanc
research
therapi
exploit
potenti
need
deliv
cell
challeng
task
mani
respect
last
decad
nanomagnet
method
deliv
target
nucleic
acid
develop
method
often
refer
magnetofect
review
summar
progress
achiev
field
research
discuss
magnet
formul
vector
nucleic
acid
deliveri
character
mechan
magnetofect
applic
magnetofect
viral
nonvir
nucleic
acid
deliveri
cell
cultur
anim
model
summar
result
obtain
use
magnetofect
basic
research
preclin
anim
model
final
describ
recent
work
end
conclus
perspect
gene
nucleic
acid
therapi
numer
research
applic
reli
introduct
nucleic
acid
cell
inform
compris
sequenc
build
block
exploit
overexpress
desir
protein
downregul
endogen
gene
express
bypass
even
repair
endogen
genet
defect
activ
innat
immun
system
substanti
progress
made
establish
optim
deliveri
system
nucleic
acid
almost
year
research
develop
date
back
first
use
nucleic
acid
deliveri
virolog
research
first
visionari
concept
gene
therapi
nucleic
acid
therapi
begin
live
expect
sinc
first
gene
therapi
clinic
trial
clinic
trial
conduct
convinc
therapeut
success
human
clinic
trial
achiev
recent
year
still
field
infanc
nucleic
acid
therapi
far
broadli
applic
two
major
limit
one
incomplet
knowledg
go
insid
cell
molecular
level
understand
suffici
well
process
govern
nucleic
acid
uptak
intracellular
interact
intracellular
traffick
regul
nucleic
acid
action
insid
cell
limit
part
result
first
one
avail
effici
afford
safe
shuttl
nucleic
acid
deliveri
socal
vector
local
action
target
cell
effici
defin
number
effector
molecul
concentr
requir
yield
desir
effect
transport
activ
ingredi
target
structur
intend
interact
becom
limit
factor
predict
hold
measur
supportsimprov
transport
improv
effici
activ
ingredi
essenti
paradigm
magnet
drug
target
date
back
activ
ingredi
associ
magnet
particl
concentr
target
site
magnet
forc
transport
target
cell
limit
factor
nucleic
acid
deliveri
least
vivo
first
idea
exploit
principl
magnet
target
nucleic
acid
deliveri
appear
patent
literatur
howev
littl
experiment
evid
last
decad
sever
research
group
implement
optim
concept
magnet
drug
target
nucleic
acid
deliveri
first
account
scientif
literatur
confer
abstract
mah
group
year
time
coin
acronym
magnetofect
sinc
wide
use
gener
term
magnet
guid
enhanc
nucleic
acid
deliveri
scientif
literatur
defin
magnetofect
nucleic
acid
deliveri
influenc
magnet
field
act
nucleic
acid
vector
associ
magnet
nano
particl
fig
simplic
use
term
throughout
review
nucleic
acid
deliveri
method
discuss
herein
base
principl
first
full
paper
field
accept
public
scientif
journal
hugh
cowork
magnet
enhanc
retrovir
nucleic
acid
deliveri
follow
later
work
nonvir
viral
magnetofect
pandori
paper
enhanc
infect
adenovirusmicrobead
conjug
mah
paper
magnet
enhanc
aav
vectormedi
gene
deliveri
public
ensu
includ
first
paper
mechan
magnetofect
paper
magnet
enhanc
oligonucleotid
deliveri
vitro
vivo
magnetofect
primari
endotheli
cell
three
review
paper
summar
state
art
time
essenti
framework
magnetofect
set
major
benefit
magnetofect
improv
doserespons
relationship
nucleic
acid
deliveri
strong
improv
kinet
deliveri
process
possibl
local
nucleic
acid
deliveri
area
magnet
field
influenc
sinc
earli
day
magnetofect
major
progress
made
intent
review
summar
progress
conclud
perspect
come
year
magnetofect
reagent
commerci
avail
contribut
exponenti
increas
number
paper
field
search
defin
fig
isi
web
scienc
deliv
hit
search
pubm
deliv
hit
combin
two
search
result
public
paper
field
nucleic
acid
deliveri
search
deliv
use
summari
field
interest
relat
field
magnet
particl
play
import
role
ie
drug
deliveri
medic
imag
magnet
cell
label
cell
track
magnet
separ
techniqu
public
origin
articl
review
proceed
paper
confer
abstract
editori
unit
state
public
germani
china
contribut
china
sharp
rise
year
year
cite
origin
articl
field
nucleic
acid
deliveri
among
combin
isi
pubm
hit
origin
magnetofect
articl
scherer
et
al
cite
review
field
berri
et
al
function
magnet
nanoparticl
biomedicin
moghimi
et
al
statu
nanomedicin
mani
excel
review
relat
field
appear
recent
reader
refer
review
appropri
top
cite
articl
field
publish
last
year
medarova
paper
vivo
imag
sirna
deliveri
gene
silenc
tumor
kim
paper
toxic
magnet
nanoparticl
mice
yu
paper
drugload
superparamagnet
iron
oxid
nanoparticl
combin
cancer
imag
therapi
broad
varieti
synthet
option
obtain
magnet
nanoparticl
biomed
applic
option
explor
nucleic
acid
deliveri
purpos
far
detail
review
properti
synthesi
iron
oxid
nanoparticl
scope
articl
excel
review
topic
publish
recent
use
magnetofect
magnet
particl
need
compris
function
allow
associ
gene
deliveri
vector
magnet
vector
vector
nucleic
acid
either
alon
combin
enhanc
nonvir
lipoplex
polyplex
viral
vector
magnet
properti
particl
suffici
concentr
vector
target
cell
magnet
forc
particl
chemic
colloid
stabil
accept
medium
must
suffici
store
requir
period
particl
formul
biocompat
enough
applic
live
cell
first
magnet
vector
viral
gene
deliveri
prepar
mah
et
al
avidinyl
polystyren
magnetit
microspher
modifi
biotinyl
heparin
sulfat
conjug
adenoassoci
viru
via
specif
interact
accord
scheme
fig
magnet
conjug
demonstr
significantli
improv
infect
vitro
vivo
administ
either
intramuscularli
intraven
allow
local
transduct
site
magnet
field
applic
vitro
sinc
first
public
numer
studi
util
affin
interact
assembl
viru
magnet
microand
nanoparticl
especi
use
strept
avidin
biotin
technolog
prove
versatil
tool
purif
concentr
target
viral
vector
biotin
coupl
viru
surfac
strept
avidin
surfac
magnet
particl
streptavidinmodifi
viral
particl
captur
biotinyl
magnet
particl
viru
modif
achiev
chemic
metabol
genet
strept
avidinco
magnet
particl
commerci
avail
exampl
streptavidin
magnespher
particl
promega
dynabead
myon
dynabead
streptavidin
coat
magnet
particl
dynal
well
biotinyl
particl
spherotech
other
versatil
approach
use
isol
concentr
viru
crude
extract
enhanc
transduct
effici
achiev
local
infect
vitro
vivo
associ
biotinlabel
retroviru
streptavidin
magnespher
promega
use
concentr
vector
receiv
infecti
paramagnet
retrovir
vector
particl
shown
produc
retrovir
conjug
magnet
attract
desir
locat
infect
adenoviru
particl
treat
sulfonhslcbiotin
conjug
streptavidin
coat
magnet
microparticl
promega
display
greater
infect
particularli
poorli
permiss
cell
control
spatial
use
magnet
forc
associ
avidin
display
baculoviru
biotinyl
magnet
microparticl
result
magnetguid
target
citat
year
magnet
nanoparticl
magnet
particl
iron
oxid
nanoparticl
gene
deliveri
gene
transfer
nucleic
acid
deliveri
nonvir
transfect
nonvir
transfect
viral
transduct
gene
therapi
nucleic
acid
therapi
rna
interfer
rnaior
sirna
gene
silenc
magnetofect
virussurfacespecif
antibodi
immobil
magnet
nanoparticl
creat
magnet
viral
nanosensor
expos
viral
particl
solut
cluster
nanoparticl
occur
correspond
chang
mr
signal
panel
reproduc
permiss
american
societi
gene
therapi
molecular
therapi
panel
b
reproduc
permiss
ac
public
molecular
pharmaceut
panel
c
reproduc
permiss
ac
public
jac
improv
transduct
captur
metabol
biotinyl
lentiviru
streptavidin
dynal
myon
particl
allow
highli
effici
process
prepar
purifi
concentr
infecti
lentivir
vector
vector
conjug
dens
particl
result
unexpectedli
larg
increas
titer
presum
promot
likelihood
interact
target
cell
even
absenc
magnet
field
chorni
et
al
achiev
enhanc
nonvir
adenovir
gene
deliveri
cultur
arteri
smooth
muscl
cell
endotheli
cell
complex
biodegrad
mnp
fluoresc
label
mnp
narrow
size
distribut
averag
diamet
nm
formul
polylactid
inclus
iron
oxid
smallsiz
nm
crystallit
surfacemodifi
domain
coxsacki
adenoviru
receptor
car
affin
linker
individu
mnp
capabl
accommod
sever
virion
surfac
shown
tem
imag
fig
significantli
increas
mnpad
mediat
transduct
compar
respect
field
control
accord
effici
cellular
uptak
magnet
condit
specif
assembl
magnet
nanoparticl
use
develop
extrem
sensit
method
detect
viru
particl
biolog
materi
interest
exploit
signific
increas
mri
relax
magnet
nanoparticl
due
assembl
result
magnet
order
superparamagnet
iron
oxid
particl
dextran
coat
hydrodynam
diamet
nm
immobil
virussurfacespecif
antibodi
specif
assembl
viru
particl
nm
shown
scheme
fig
h
incub
origin
viral
particl
popul
becam
undetect
larger
nanoassembl
size
nm
detect
assembl
result
dramat
increas
mri
relax
thu
allow
sensit
detect
viral
particl
serum
measur
chang
water
relax
time
approach
develop
detect
varieti
speci
includ
dna
mrna
protein
small
moleculesdrug
bacteria
tumor
cell
method
design
diagnost
magnet
reson
dmr
inventor
neg
charg
phosphat
backbon
nucleic
acid
well
neg
electrokinet
zeta
potenti
type
viral
particl
aqueou
media
allow
assembl
cation
speci
particl
due
electrostat
induc
aggreg
scheme
fig
hydrophob
region
surfac
viru
particl
provid
adsorpt
site
make
associ
lipid
hydrophob
interact
possibl
cationiclipidencapsul
adenoviru
particl
show
enhanc
bind
cell
membran
higher
uptak
endosom
escap
cardefici
cell
thu
also
magnet
nanoparticl
possess
cation
charg
andor
compris
hydrophob
structur
coat
structur
make
use
electrostat
hydrophob
interact
selfassembl
viru
particl
magnet
transduct
vector
first
magnet
coreshel
nanoparticl
special
design
gene
deliveri
iron
oxid
nanoparticl
stabil
high
molecular
poli
ethylen
imin
kda
call
transmag
pei
prepar
chemicel
gmbh
berlin
germani
particl
averag
hydrodynam
diamet
nm
dynam
light
scatter
posit
electrokinet
potenti
mv
measur
aqueou
suspens
formul
magnet
nonvir
viral
vector
transmag
pei
nanoparticl
formul
magnet
nanoparticl
alon
enhanc
transfect
transduct
applic
magnet
field
rais
report
gene
express
level
three
order
magnitud
achiev
nonmagnet
vector
condit
magnet
adenoviru
complex
appli
magnet
field
effici
transduc
cell
express
littl
coxsacki
adenoviru
receptor
car
otherwis
nonpermiss
adenovir
infect
later
maghemit
nanoparticl
decor
pei
associ
retrovir
vector
well
combimag
nanoparticl
chemicel
associ
measl
viru
concentr
viru
increas
transduct
effici
protocol
highli
effici
transfect
primari
neuron
magnet
vector
formul
combimag
nanoparticl
avail
shi
et
al
prepar
magnet
nanoparticl
effect
magnetofect
stabil
hyperbranch
poli
ethylen
imin
differ
molecular
weight
formul
differ
peicoat
superparamagnet
iron
oxid
nanoparticl
complex
dna
gene
transfect
well
detail
characterist
particl
present
ref
toxic
magnet
polyplex
found
lower
compar
polyplex
alon
polym
surfactantslipid
known
use
particl
stabil
andor
gene
deliveri
alreadi
use
design
new
iron
oxid
nanoparticl
nucleic
acid
viral
deliveri
one
exampl
nacyl
chitosan
stabil
iron
oxid
nanoparticl
electrokinet
potenti
mv
hydrodynam
diamet
nm
measur
pb
particl
selfassembl
dna
adenovir
particl
complex
effici
transfect
transduct
suspens
type
cell
magnetofect
chorni
et
al
formul
biodegrad
polylactid
mnp
contain
oleateco
magnetit
surfac
modifi
pei
oleat
enabl
dna
bind
larger
particl
nm
diamet
exhibit
higher
transfect
rate
cultur
arteri
smooth
muscl
cell
endotheli
cell
exposur
magnet
field
compar
nmand
nmsize
mnp
recent
mesopor
silica
particl
decor
magnetit
nanocryst
thermal
decomposit
iron
iii
acetylaceton
result
composit
magnetitesilica
particl
around
nm
iron
oxid
content
ca
ww
coat
poli
ethylen
imin
kda
associ
dna
result
effect
transfect
human
lung
mucoepidermoid
carcinoma
cell
superior
lipofectamin
effici
wu
et
al
render
synthet
hydroxyapatit
natur
bone
miner
magnet
treatment
iron
salt
wetchem
process
composit
magnet
particl
nm
diamet
associ
dna
effici
transfect
rat
marrowderiv
mesenchym
stem
cell
formul
compris
cation
cellpenetr
tatpeptid
affin
molecul
specif
target
allow
improv
deliveri
effici
kievit
et
al
mok
et
al
report
use
chlorotoxin
target
iron
oxid
nanoparticl
load
dna
sirna
enhanc
uptak
specif
glioma
cell
vitro
vivo
iron
oxid
nanoparticl
coat
formul
poli
ethylen
imin
averag
mw
kda
chitosan
medium
molecular
weight
methoxi
poli
ethylen
glycol
mw
kda
select
leader
librari
inhous
synthes
iron
oxid
nanoparticl
associ
vector
differ
coat
materi
effici
gene
deliveri
magnetofect
nonvir
viral
vector
tabl
particl
surfac
coat
consist
fluorin
surfact
zonyl
fsa
lithium
perfluoroalkyl
ethylthio
propion
combin
branch
poli
ethylen
imin
br
hereaft
refer
particl
refer
surfac
coat
result
condens
tetraethyl
orthosil
trihydroxysilyl
propylmethylphosphon
surfac
follow
surfac
decor
nanomateri
via
spontan
adsorpt
br
particl
synthes
surfac
coat
formul
zonyl
fsa
refer
particl
synthes
presenc
zonyl
fsa
pluron
refer
particl
particl
synthes
describ
elsewher
use
palmitoyl
dextran
shell
compon
mean
core
crystallit
size
b
n
calcul
broaden
xray
diffract
peak
use
scherrer
formula
mean
hydrodynam
diamet
zeta
potenti
mnp
suspens
water
determin
pc
magnet
data
term
emu
per
g
iron
taken
togeth
data
mean
crystallit
size
allow
estim
averag
magnet
moment
individu
particl
paramet
optim
find
optim
vector
formul
intend
applic
type
ratio
magnet
nanoparticl
dna
viru
particl
ensur
quantit
vector
associ
nanoparticl
give
highest
transgen
express
accept
toxic
interestingli
cation
magnet
nanoparticl
also
neg
charg
particl
associ
neg
charg
nucleic
acid
viru
particl
presenc
cation
polym
andor
lipid
enhanc
haim
coauthor
associ
neg
charg
transmagpd
nanoparticl
chemicel
lentiviru
particl
enhanc
synchron
infect
cell
cultur
associ
neg
charg
viru
magnet
nanoparticl
facilit
posit
charg
ion
solut
similar
approach
assembl
lentiviru
particl
neg
charg
magnet
nanoparticl
hbss
util
hofmann
et
al
alreadi
first
origin
articl
group
use
quantit
approach
magnet
vector
formul
includ
test
associ
magnet
sediment
radioact
label
dna
adenoviru
magnet
nanoparticl
function
mnpstonucl
acid
ww
ratio
mnpstovp
ratio
adenoviru
almost
complet
magnet
sediment
vector
exposur
develop
ndfeb
magnet
array
achiev
transmag
pei
dna
ratio
ww
nake
dna
peidna
np
polyplex
dotapcholesteroldna
lipoplex
tai
et
al
synthes
monodispers
maghemit
nanoparticl
averag
size
nm
thermolysi
organ
precursor
modifi
particl
pei
coat
associ
result
nm
cluster
retrovir
vector
result
consider
improv
local
transduct
confin
area
magnet
field
applic
author
claim
ratio
peimodifi
mnp
vector
critic
approach
find
optim
magnet
vector
formul
plasmid
sirna
viral
vector
deliveri
exampl
data
shown
fig
aim
maxim
associ
magnet
compon
avoid
excess
magnet
particl
learn
excess
magnet
nanoparticl
inhibit
transfectiontransduct
effici
caus
toxic
optim
mnpstonucl
acid
ratio
unit
iron
weight
per
unit
nucleic
acid
weight
triplex
enhanc
well
mnpstoviru
ratio
fg
iron
per
viru
particl
refer
fg
fevp
turn
use
varieti
magnet
nanoparticl
type
like
present
tabl
complex
formul
way
effici
hardli
toxic
deliveri
dna
sirna
well
deliveri
adenovir
lentivir
vector
vitro
ex
vivo
cell
cultur
primari
cell
detail
protocol
synthesi
particl
well
formul
magnet
gene
deliveri
complex
coreshel
nanoparticl
publish
hydrodynam
diamet
electrokinet
potenti
stabil
presenc
protein
characterist
determin
magnet
vector
formul
data
lipoplex
select
magnet
lipoplex
irontodna
ww
ratio
prepar
rpmi
medium
without
addit
given
tabl
averag
size
magnet
nonmagnet
transfect
complex
luciferas
egfp
plasmid
vari
nm
almost
nm
complex
posit
net
charg
except
slightli
neg
charg
magnet
lipoplex
nanoparticl
appli
simpl
method
evalu
magnet
respons
magnetophoret
mobil
averag
veloc
complex
magnet
microbubbl
magnet
label
cell
defin
magnet
field
previous
describ
method
time
cours
optic
densiti
turbid
record
exposur
gradient
magnet
field
averag
veloc
magnet
field
gradient
evalu
lt
l
averag
path
complex
movement
perpendicular
measur
light
beam
time
requir
tenfold
decreas
optic
densiti
calcul
averag
magnet
moment
magnet
complex
estim
number
mnp
n
associ
complex
perform
use
approach
describ
detail
wilhelm
et
al
account
hydrodynam
diamet
core
size
complex
magnet
nanoparticl
similar
approach
also
appli
evalu
data
quantit
magnetophoresi
live
cell
deriv
estim
iron
load
magnet
label
cell
time
cours
turbid
magnet
lipoplex
plot
fig
show
nonvir
magnet
complex
sediment
within
min
appli
magnet
field
deriv
magnetophoret
mobil
complex
averag
hydrodynam
diamet
complex
nm
allow
one
estim
averag
magnet
moment
complex
averag
number
magnet
nanoparticl
associ
complex
particl
per
complex
shown
fig
experiment
approach
could
use
experiment
estim
kinet
magnet
sediment
new
magnet
complex
choos
proper
pdna
associ
magnet
nanoparticl
triplex
dfgold
dna
plot
magnet
nanoparticl
concentr
term
iron
concentr
irontopdna
ww
ratio
b
viru
associ
magnet
nanoparticl
stabil
result
complex
fc
magnet
sediment
complex
ilabel
viru
magnet
nanoparticl
mix
optimem
variou
nanoparticletoviru
particl
ratio
final
viru
concentr
complex
assembl
vpml
incub
min
form
complex
result
complex
dilut
optimem
fc
incub
min
posit
plate
h
magnet
sediment
complex
radioact
supernat
measur
quantifi
percentag
viru
associ
magnet
sediment
mnp
c
selfinactiv
lentivir
vector
associ
viromag
rl
mnp
lentiviru
particl
mix
magnet
nanoparticl
rpmi
cell
cultur
medium
supplement
fc
magnet
nanoparticl
physic
viru
particl
ratio
fg
fevp
incub
min
form
complex
result
complex
posit
magnet
plate
min
sediment
complex
concentr
viru
particl
supernat
determin
use
elisa
quantifi
percentag
viru
particl
associ
magneticallysedi
magnet
nanoparticl
panel
reproduc
permiss
indersci
enterpris
ltd
panel
b
reproduc
permiss
ac
public
molecular
pharmaceut
panel
paramet
magnet
field
exposit
necessari
achiev
full
sediment
complex
fulfil
magnet
target
magnet
lipoplex
rel
larg
nm
comparison
nonmagnet
lipoplex
nm
surfac
charg
rang
slightli
neg
posit
ev
measur
absenc
serum
tabl
transfect
jurkat
cell
high
effici
jurkat
cell
egfpposit
detect
fluorescenceactiv
cell
sort
correct
weak
fluoresc
lipid
enhanc
maintain
viabil
cell
net
charg
complex
turn
slightli
neg
serumcontain
medium
affect
intern
final
gene
express
level
convers
posit
neg
zeta
potenti
serumcontain
medium
also
observ
magnet
complex
adenoviru
data
shown
tabl
accord
magnetophoret
mobil
measur
mnp
associ
lipid
compon
plasmid
complex
result
averag
magnet
moment
satur
magnet
observ
role
size
lipoplex
transfect
effici
found
previou
literatur
ogri
et
al
report
aggreg
dnatfpei
complex
averag
size
larger
nm
result
effici
gene
transfer
smaller
particl
ross
hui
provid
evid
size
dotapdop
lipoplex
major
determin
intern
transfect
effici
found
largest
complex
effici
chines
hamster
ovari
cell
li
et
al
found
size
surfac
charg
major
determin
vitro
lipofect
effici
cation
lipidpdna
complex
observ
direct
relationship
size
complex
transfect
effici
complex
larg
deliv
gene
effici
nevertheless
complex
averag
hydrodynam
diamet
nm
also
effici
like
formul
nanoparticl
result
indic
size
charg
magnet
vector
test
critic
import
gene
deliveri
jurkat
cell
appar
fine
differ
composit
surfac
layer
particl
caus
signific
differ
effici
deriv
magnet
lipoplex
observ
particl
sirna
magnet
vector
optim
sirna
deliveri
cell
cultur
tabl
hydrodynam
diamet
nm
posit
electrokinet
potenti
triplex
compris
insul
magnet
nanoparticl
ie
magnetit
crystallit
determin
magnet
respons
measur
effect
formul
gene
silenc
experi
shown
fig
vector
compris
sirna
silencemag
oz
biosceinc
peimodifi
magnet
nanoparticl
pei
metafecten
biontex
enhanc
silenc
report
protein
express
hela
cell
achiev
use
magnet
sirna
deliveri
vector
administ
sirna
concentr
low
nm
fig
investig
interact
endotheli
synthas
eno
modul
endotheli
function
human
umbil
vein
endotheli
cell
transfect
nm
sirna
complex
particl
sirna
ratio
ww
np
ratio
succeed
decreas
express
level
argaw
et
al
synthes
crosslink
dextran
coat
iron
oxid
nanoparticl
modifi
particl
coupl
cation
dendrim
transmiss
electron
microscopi
particl
found
adopt
worm
shape
multipl
nm
iron
oxid
core
line
seri
author
call
chain
aggreg
particl
dendriworm
net
charg
averag
hydrodynam
diamet
dendriworm
found
mv
zetapotenti
measur
pb
nm
respect
roughli
sirna
molecul
bound
per
iron
core
dendriworm
nm
magnetit
particl
averag
particl
weight
term
iron
weight
account
magnetit
densiti
gcm
g
ironparticl
ten
sirna
molecul
bound
per
iron
oxid
nanoparticl
dendriworm
formul
correspond
account
averag
sirna
molecular
weight
gmol
g
sirna
associ
g
iron
irontosirna
ratio
ww
almost
downregul
egfr
protein
express
human
primari
glioblastoma
cell
achiev
nm
egfr
sirna
appli
formul
dendriworm
signific
suppress
egfr
express
level
achiev
formul
transgen
mous
model
glioblastoma
result
selfassembl
adenoviru
particl
provid
evid
high
associ
viru
magnet
nanoparticl
high
stabil
presenc
fc
complex
assembl
optimem
pb
rang
particletoviru
ratio
fg
fevp
fig
stabil
complex
reduc
fc
howev
viru
still
magnet
sediment
rang
fg
fevp
min
incub
presenc
fc
complex
format
result
shift
zeta
potenti
neg
free
viru
tabl
fg
fevp
posit
plateau
mv
magnet
particletoviru
ratio
fg
fevp
magnet
moment
complex
calcul
averag
veloc
magnetophoret
mobil
assay
allow
us
calcul
estim
mnptoviru
ratio
complex
tabl
calcul
mnp
per
viru
particl
optim
complex
composit
measur
hydrodynam
diamet
nm
suggest
layer
dens
pack
magnetit
crystallit
arrang
around
viru
particl
due
electrostat
interact
possibl
due
magnet
dipoledipol
interact
magnet
particl
afm
tem
imag
confirm
adenoviru
associ
nanoparticl
fig
structur
integr
viru
impair
associ
mnp
taken
togeth
magnetophoret
mobil
measur
particl
size
afm
tem
suggest
model
multipl
layer
magnetit
crystallit
associ
viru
particl
sever
viru
particl
link
mnp
import
issu
associ
viru
nanoparticl
interfer
oncolyt
activ
reproduc
permiss
indersci
publish
int
j
biomed
nanosci
nanotechnolog
vitro
rather
slight
enhanc
effect
even
without
magnet
field
applic
observ
viru
uptak
independ
car
express
cell
recent
kamei
et
al
prepar
goldironoxid
magnet
nanoparticl
goldman
precipit
au
particl
presenc
nanoparticl
averag
diamet
nm
result
goldman
h
nm
associ
adenoviru
vector
satur
viru
bind
occur
fg
goldman
per
vp
complex
stabl
extend
period
fetal
bovin
serum
complex
formul
fg
goldmanvp
highli
effici
transduct
car
mous
melanoma
cell
presenc
magnet
field
cell
entri
adlucgoldman
found
carindepend
due
intrins
properti
particl
author
specul
coupl
occur
particl
activ
group
viru
surfac
ito
et
al
modifi
commerci
magnetit
nanoparticl
averag
particl
size
nm
liposom
consist
n
trimethylammonioacetyl
dodecyldglutam
chlorid
dilauroylphosphatidylcholin
dioleylphosphatidylethanolamin
molar
ratio
result
magnet
cation
liposom
mcl
zetapotenti
mv
compar
poli
ethylen
imin
coat
transmag
pei
nanoparticl
describ
tabl
averag
hydrodynam
diamet
nm
appli
mg
mclsml
crude
viru
prepar
concentr
magnet
viru
associ
particl
result
show
magnetofect
result
significantli
lower
express
level
gfp
ie
effici
target
gene
downregul
compar
lipoor
polyfect
vector
type
effici
complex
compar
magnetofectionbas
formul
oz
bioscienc
call
silencemag
magnet
duplex
irontosirna
ratio
deliv
sirna
rather
effici
less
effici
compar
magnet
triplex
formul
irontosirna
ratio
reproduc
permiss
humana
press
method
molecular
biolog
result
increas
viru
titer
magnet
viru
effici
transduc
mous
neuroblastoma
cell
local
transduct
area
due
applic
magnet
field
possibl
observ
also
made
excess
magnet
particl
mg
per
millilit
crude
viru
prepar
decreas
effici
viru
titer
concentr
show
optimum
ratio
magnet
particlestoviru
coval
coupl
vector
magnet
nanoparticl
use
rel
rare
medarova
et
al
describ
multimod
iron
oxid
magnet
nanoparticl
sirna
deliveri
vivo
dextranco
amin
nanoparticl
coval
coupl
nearinfrar
fluoresc
probe
sirna
antigfp
antisurvivin
myristoyl
polyarginin
peptid
mpap
mpap
serv
membran
transloc
modul
allow
optic
imag
averag
one
nanoparticl
carri
three
four
mpap
five
sirna
molecul
passiv
accumul
function
deliveri
sirna
tumor
tissu
achiev
tumor
use
nanoparticl
follow
intraven
administr
mice
howev
magnet
properti
nanoparticl
exploit
magnet
target
magnet
fieldenhanc
transfect
rather
serv
contrast
agent
mri
huh
et
al
coval
coupl
manganeseiron
nanoparticl
stabil
acid
core
nm
capsid
lysin
residu
adenovirus
activ
sulfosuccinimidyl
conjug
kept
intrins
high
low
adenoviru
infect
carposit
carneg
cell
respect
evert
et
al
coval
coupl
sulfonhydroxysuccinimid
label
gold
nanoparticl
adenovir
vector
viru
infect
maintain
load
gold
particl
per
viru
particl
wherea
higher
load
inhibit
transduct
effici
lentivir
vector
metabol
label
biotin
high
affin
streptavidin
magnet
particl
captur
easili
manipul
vitro
illustr
concentr
lentivir
vector
pseudotyp
either
vsvg
amphotrop
envelop
excess
first
studi
huth
et
al
publish
indic
probabl
fundament
mechanist
differ
magnetofect
gene
deliveri
analog
nonmagnet
vector
studi
use
magnet
nonmagnet
complex
plasmid
dna
poli
ethylen
imin
pei
transfect
reagent
frequent
use
among
cation
polym
magnet
complex
use
studi
consist
pei
dna
peicoat
iron
oxid
magnet
nanoparticl
assembl
saltinduc
aggreg
bind
cell
surfac
nonmagnet
peidna
complex
intern
intracellular
vesicl
call
endosom
natur
uptak
process
endocytosi
escap
endosom
thought
essenti
function
nucleic
acid
deliveri
otherwis
vector
would
degrad
cellular
breakdown
machineri
peidna
complex
thought
escap
due
socal
proton
spong
effect
pei
virtu
secondari
tertiari
amin
buffer
capac
physiolog
ph
consequ
peidna
particl
intern
cell
endocytosi
buffer
natur
acidif
process
within
endosom
mean
endosom
proton
pump
need
pump
way
proton
endosom
natur
acid
endosom
ph
reach
proton
spong
hypothesi
postul
enhanc
gene
deliveri
due
buffer
capac
polym
structur
featur
like
pei
enhanc
endosom
chlorid
accumul
concomit
influx
water
consequ
osmot
swellinglysi
sonawan
et
al
provid
experiment
evid
support
hypothesi
huth
et
al
use
electron
microscopi
variou
inhibitor
endocytot
uptak
figur
whether
magnetofect
peidna
complex
might
proceed
via
nonendocytot
pathway
also
use
centrifug
sediment
magnet
standard
vector
cell
surfac
found
subsequ
applic
magnet
field
lead
increas
gene
transfer
effici
conclus
studi
uptak
mechan
magnet
peidna
virtual
standard
peidna
line
result
mechanist
experi
namgung
et
al
carri
recent
differ
peicoat
magnet
nanoparticl
recent
studi
sauer
et
al
magnet
lipoplex
use
singl
particl
track
came
conclus
similar
nonmagnet
pei
polyplex
observ
three
phase
behavior
phase
magnet
lipoplex
attach
cell
surfac
show
slow
cooper
transport
major
lipoplex
intern
via
endocytosi
phase
phase
ii
character
anomal
confin
diffus
insid
cell
phase
iii
repres
activ
transport
along
microtubul
insid
cell
later
time
point
format
perinuclear
ring
observ
persist
coloc
fluid
phase
marker
lipoplex
h
indic
slow
endosom
releas
perinuclear
accumul
also
observ
previou
studi
li
et
al
two
thorough
recent
studi
arsianti
et
al
provid
mechanist
insight
particular
concern
import
biophys
properti
magnet
vector
effici
gene
deliveri
author
also
use
triplex
pei
dna
iron
oxid
magnet
nanoparticl
mnp
synthes
differ
manner
setup
also
provid
pei
coat
one
examin
case
arsianti
find
indic
major
uptak
pathway
vector
endocytosi
via
clathrin
coat
pit
rather
via
caveolaedepend
pathway
via
macropinocytosi
mix
order
vector
compon
import
impact
result
biophys
properti
size
zeta
potenti
surfac
characterist
influenc
aggreg
behavior
adsorpt
serum
protein
time
extent
vector
uptak
intracellular
process
brief
three
compon
pei
dna
magnet
nanoparticl
assembl
manner
pei
display
particl
surfac
posit
zeta
potenti
water
serum
protein
adsorb
revers
surfac
charg
eventu
redispers
composit
previous
aggreg
one
conclud
essenti
character
vector
context
biolog
surround
encount
nucleic
acid
deliveri
process
composit
pei
surfac
display
rapid
uptak
releas
endolysosom
effect
gene
deliveri
composit
dna
surfac
neg
zeta
potenti
water
also
taken
cell
low
rate
endolysosom
releas
consequ
function
gene
deliveri
ineffici
henc
matter
compon
chosen
construct
magnet
vector
assembl
uptak
alon
suffici
function
nucleic
acid
deliveri
effici
magnet
vector
requir
function
modul
product
intracellular
process
modul
need
display
right
configur
arsianti
studi
highlight
import
aspect
vector
composit
compet
function
gene
deliveri
also
toxic
one
howev
common
mani
nonvir
deliveri
system
especi
compris
pei
toxic
question
vector
dose
coat
magnet
particl
especi
transfect
reagent
chosen
assembl
magnet
vector
shown
highli
effici
rather
nontox
vector
obtain
magnet
lipoplex
recent
studi
peicoat
magnet
nanoparticl
differ
size
assembl
dna
ang
et
al
show
given
rel
high
vector
dose
magnet
flux
densiti
appli
min
magnetofect
play
role
respect
transfect
effici
cell
viabil
howev
observ
probabl
due
fraction
high
toxic
vector
dose
becam
magnet
sediment
cell
incub
time
rather
potenti
toxic
magnet
field
base
publish
literatur
one
conclud
nonvir
magnetofect
static
field
condit
involv
deliveri
mechan
cell
surfac
cell
differ
nonmagnet
nucleic
acid
deliveri
improv
doserespons
relationship
acceler
transfect
kinet
appear
entir
due
rapid
sediment
full
appli
vector
dose
target
cell
surfac
within
minut
diffus
barrier
exist
vector
particl
small
sediment
gravit
forc
overcom
accord
model
calcul
furlani
ng
increas
vector
dose
cell
surfac
result
increas
intern
dose
within
given
time
period
unless
uptak
process
becom
satur
fig
alon
necessarili
lead
improv
function
nucleic
acid
deliveri
therefor
order
classifi
vector
composit
term
efficaci
use
normal
observ
effect
eg
report
gene
express
percentag
transfect
cell
extent
gene
silenc
intern
nucleic
acid
viru
dose
true
measur
qualiti
vector
composit
term
mechan
peculiar
nonmagnet
magnet
adenovirus
natur
infect
viru
govern
presenc
absenc
receptor
viru
need
bind
cell
coxsacki
adenoviru
receptor
car
absenc
requir
receptor
viru
infect
unless
decor
addit
bind
modul
magnet
nanoparticl
provid
function
magnetofect
enforc
infect
even
absenc
viru
receptor
assum
intrins
mechan
adenovir
infect
chang
magnetofect
import
impact
simpl
associ
magnet
nanoparticl
viru
enabl
therapeut
applic
efficaci
would
limit
otherwis
similar
enabl
viral
infect
nonpermiss
cell
magnetofect
observ
kadota
et
al
measl
viru
despit
conclus
cellular
uptak
process
like
magnet
nonmagnet
vector
case
evid
magnet
field
influenc
enhanc
tissu
penetr
magnet
particl
magnet
cell
magnet
vector
muthana
et
al
establish
vitro
model
assess
monocyt
extravas
tumor
spheroid
endotheli
cell
layer
shown
transfect
magnet
particleload
monocyt
induc
magnet
forc
migrat
endotheli
layer
penetr
tumor
spheroid
fig
similarli
zhang
et
al
cultur
cell
collagen
matrix
shown
magnet
vector
penetr
matrix
magnet
field
influenc
transfect
cell
context
interest
note
accord
studi
macdonald
et
al
timevari
magnet
field
enhanc
transport
magnet
nanoparticl
viscou
gel
fig
respect
nucleic
acid
deliveri
influenc
altern
pulsat
field
deserv
increas
interest
sever
public
indic
nonstat
field
use
improv
effici
magnetofect
earliest
observ
respect
kamau
et
al
use
magnet
devic
socal
dynam
marker
produc
rel
complex
pulsat
field
sinu
type
wave
perpendicular
cell
cultur
plate
overlay
field
modul
plane
cell
cultur
plate
low
frequenc
author
specul
altern
field
may
caus
oscil
magnet
particl
may
facilit
cellular
uptak
particl
bound
cell
surfac
realli
happen
understood
case
use
techniqu
kamau
et
al
achiev
quit
substanti
improv
percentag
transfect
cell
varieti
cell
line
combin
premagnet
perman
field
follow
applic
dynam
field
result
synergist
enhanc
group
extend
work
report
transfect
primari
synoviocyt
chondrocyt
osteoblast
melanocyt
macrophag
lung
fibroblast
embryon
fibroblast
chen
et
al
use
differ
setup
puls
magnet
field
millisecond
durat
rapid
transfect
adher
suspens
cell
pulsat
field
use
also
magnetotransform
method
transfer
plasmid
dna
escherichia
coli
plasmid
dna
attach
peicoat
magnet
nanoparticl
highest
transform
effici
achiev
puls
three
time
magnet
field
transform
effici
cell
viabil
depend
magnet
particl
dna
dose
well
number
magnet
field
puls
differ
conveni
method
produc
dynam
field
develop
jon
dobson
group
convent
magnetofect
cell
incub
magnet
vector
cell
cultur
plate
posit
magnet
array
produc
static
gradient
field
dobson
devic
commerci
avail
wwwnanothericscom
magnet
array
wobbl
xy
plane
low
frequenc
hz
cell
cultur
plate
suitabl
amplitud
turn
use
optim
condit
substanti
enhanc
transfect
effici
achiev
pickard
chari
shown
system
provid
consider
enhanc
magnetofect
primari
astrocyt
current
underli
mechan
well
understood
one
guess
later
movement
magnet
field
transmit
mechan
forc
cellular
membran
via
magnet
vector
associ
membran
mechan
stimuli
effect
cellular
membran
traffic
includ
endoand
exocytosi
context
interest
note
magnet
actuat
cellular
process
hot
research
topic
mannix
et
al
shown
magnet
bead
decor
specif
receptor
ligand
exploit
trigger
via
magnet
induct
receptor
cluster
signal
process
mast
cell
involv
immun
surveil
particular
case
receptor
cluster
lead
rapid
rise
intracellular
calcium
known
calcium
play
import
role
endosomallysosom
fusion
process
futur
research
need
find
exactli
altern
field
influenc
magnetofect
process
applic
genet
engin
cell
one
appeal
featur
magnetofect
necessarili
produc
magnet
label
cell
thu
magnetofect
cell
offer
opportun
posit
magnet
forc
track
mri
well
optic
imag
virtu
express
report
gene
luciferas
fluoresc
protein
gene
one
advantag
report
gene
imag
viabl
cell
produc
report
signal
quantifi
intern
magnet
vector
found
variou
cell
type
easili
incorpor
pg
iron
per
cell
magnetofect
appli
vector
dose
correspond
littl
pg
iron
per
cell
account
satur
magnet
magnet
nanoparticl
use
studi
emug
fe
intern
pg
fecel
would
result
magnet
moment
emu
per
cell
comparison
polyak
et
al
abl
magnet
target
bovin
aortic
endotheli
cell
load
polymer
superparamagnet
nanoparticl
result
magnet
moment
emucel
steel
stent
wire
suffici
sensit
detect
cardiac
mri
achiev
cell
incorpor
picogram
quantiti
iron
oxid
evid
cell
incorpor
even
magnet
materi
achiev
standard
magnetofect
condit
would
use
improv
magnet
cell
posit
engraft
detect
mri
therefor
wonder
whether
preload
cell
magnet
nanoparticl
interfer
magnetofect
effici
thu
preload
cell
magnet
nanoparticl
see
tabl
fig
intern
pg
iron
per
cell
gave
rise
magnet
moment
emu
per
cell
suffici
engraft
cell
onto
lumin
surfac
tube
radial
magnet
field
subsequ
mnplabel
cell
magnetofect
nonvir
vector
associ
magnet
nanoparticl
radial
magnet
field
similar
experi
carri
standard
cultur
format
magnet
prelabel
cell
interfer
even
increas
effici
magnetofect
without
caus
toxic
fig
cell
label
mnp
result
high
transvers
relax
r
mm
manner
multiecho
gradient
echo
imag
r
map
detect
ca
mnplabel
cell
local
within
fibrin
clot
well
mnplabel
cell
monolay
engraft
lumin
surfac
cell
cultur
tube
use
radial
magnet
field
mention
enhanc
magnetofect
effici
preload
cell
mnp
confirm
anoth
experi
mesenchymallik
stem
cell
isol
umbil
cord
preload
intern
dose
pg
fecel
result
twofold
increas
transduct
effici
compar
cell
label
magselectofect
microbead
enhanc
observ
term
overal
report
gene
express
well
term
percentag
transduc
cell
fig
increas
transfectiontransduct
effici
may
due
local
field
gradient
gener
intern
mnp
expos
extern
field
would
result
addit
magnet
forc
vicin
cell
improv
attract
gene
vector
immedi
surround
phenomenon
known
avalanch
effect
util
exampl
avil
et
al
improv
target
magnet
drug
use
implant
ferromagnet
element
wire
needl
cathet
stent
increas
magnet
forc
local
increas
gradient
field
close
cell
summar
benefit
magnetofect
sever
review
method
paper
well
book
chapter
previous
sever
group
work
develop
technolog
except
use
dynam
magnet
field
innov
magnet
vector
formul
discuss
novel
approach
extend
concept
magnetofect
discuss
major
methodolog
chang
magnetofect
compar
earlier
review
paper
among
group
work
magnet
vector
develop
experi
cell
cultur
serv
primarili
purpos
vector
character
mechanist
studi
proceed
vivo
studi
methodolog
step
cell
cultur
exampl
inevit
necessari
ex
vivo
nucleic
acid
therapi
genet
modifi
cell
combin
concept
magnet
cell
posit
cell
track
magnet
reson
imag
concept
gain
increas
import
emerg
field
cell
therapi
sinc
magnetofect
reagent
commerci
avail
www
ozbiosciencescom
wwwchemicellcom
method
mostli
use
research
tool
publish
studi
numer
discuss
detail
updat
tabl
cell
type
studi
involv
magnetofect
found
websit
commerci
provid
user
magnetofect
take
advantag
featur
method
transfectiontransduct
protocol
provid
manner
featur
includ
low
dose
requir
rapid
transfectiontransduct
kinet
possibl
synchron
transfectiontransduct
benefici
vector
avail
low
amount
eg
low
viral
titer
long
incub
time
cell
cultur
lead
vector
inactiv
toxic
target
cell
use
viral
magnetofect
system
express
transgen
often
significantli
higher
comparison
viru
alon
infect
enhanc
shown
sever
model
primari
cell
especi
peripher
blood
mononuclear
cell
pbmc
primari
cell
neurosci
applic
instanc
featur
magnetofect
enabl
studi
otherwis
could
perform
highlight
discuss
use
magnetofect
thoma
et
al
highlight
inadequaci
common
viral
titer
determin
respect
ratio
infecti
defect
viral
particl
report
approxim
virion
initi
revers
transcript
form
provirus
contrari
commonli
report
ratio
addit
demonstr
titer
equival
number
infecti
particl
probabl
due
infrequ
occurr
success
viruscel
interact
standard
condit
line
observ
adenoviru
coren
thoma
et
al
also
use
magnetofect
show
import
ctermin
sequenc
gag
protein
effici
viral
dna
integr
infect
vitro
appar
gain
viral
titer
sever
thousandfold
describ
first
hugh
et
al
retrovir
vector
later
also
chan
et
al
amphotrop
murin
leukemia
viru
lentivir
vector
strategi
biotinyl
viral
surfac
protein
use
strept
avidinco
magnet
nanoparticl
captur
concentr
viru
similarli
kaikkonen
et
al
use
eleg
techniqu
metabol
label
baculoviru
biotin
group
also
publish
strategi
integr
avidin
streptavidin
viral
surfac
protein
genet
engin
use
virus
magnet
target
rather
novel
dual
imag
method
sever
studi
magnetofect
exploit
hiv
research
exampl
wang
et
al
develop
novel
method
allow
rapid
character
resist
mutant
virus
antivir
agent
assay
base
commerci
avail
magnetofect
reagent
mutant
virus
captur
magnet
nanobead
use
infect
gaggfp
report
cell
manner
suscept
breakthrough
virus
collect
resist
select
proteas
inhibitor
exampl
character
much
faster
tediou
time
consum
tradit
phenotyp
assay
util
magnetofect
synchron
viral
infect
highlight
haim
et
al
exploit
highli
use
protocol
meantim
develop
hiv
vaccin
exampl
requir
precis
understand
immunolog
virolog
principl
hiv
infect
synchron
hiv
infect
vitro
facilit
studi
event
viral
replic
cycl
antivir
immun
respons
short
timescal
previous
imposs
combin
high
transduct
effici
magnetofect
increas
throughput
vitro
assay
includ
cell
assay
requir
viral
infect
cell
synchron
critic
paramet
studi
kinet
viral
infect
well
identifi
key
focu
vaccin
develop
especi
term
viral
protein
earli
late
better
induc
specif
cell
immun
respons
exampl
magnetofect
allow
investig
kinet
siv
peptid
epitop
present
cell
defin
conform
state
dynam
hiv
env
magnetofect
use
show
gagspecif
cell
recogn
infect
lymphocyt
earli
h
postinfect
provir
dna
integr
viral
protein
synthesi
nefmedi
mhc
class
downregul
use
magnetofect
sacha
et
al
show
earli
present
incom
virionderiv
gag
epitop
maxim
h
postinfect
gag
epitop
present
due
de
novo
synthesi
occur
h
also
show
penetr
virionassoci
protein
cytoplasm
suffici
gener
cell
epitop
earli
infect
also
studi
synchron
infect
magnetofect
key
defin
kinet
epitop
present
infect
cell
well
infect
macrophag
payn
et
al
use
magnetofectionbas
viral
synchron
cell
highlight
previous
unrecogn
role
play
polspecif
respons
hlab
immun
control
hiv
studi
lead
conclus
earli
present
gag
pol
epitop
contribut
elimin
virallyinfect
cell
viral
dissemin
therefor
kinet
advantag
hlab
infect
individu
abl
produc
cell
respons
epitop
magnetofect
allow
mann
et
al
shed
light
import
cryptic
major
histocompat
complex
class
epitop
immun
respons
toward
siv
defin
two
novel
translat
product
siv
env
mrna
target
cell
respons
apart
valuabl
research
tool
virolog
magnetofect
cours
use
tool
gene
therapi
research
exampl
barsov
et
al
use
magnetofect
select
immort
tumorspecif
cell
establish
longterm
tcell
line
maintain
primari
cell
characterist
abil
isol
maintain
character
tumorspecif
cell
prerequisit
studi
anticanc
immun
respons
develop
novel
strategi
cancer
immunotherapi
howev
life
span
human
cell
vitro
usual
short
limit
onset
cellular
senesc
solv
problem
immort
antigenrespons
cell
human
peripher
blood
mononuclear
cell
pbmc
produc
magnetofect
cell
mlv
vector
carri
immort
gene
human
telomeraserevers
transcriptas
gene
magnetofect
also
use
transduc
airway
epitheli
cell
lentivir
vector
gene
deliveri
process
cell
hamper
extracellular
barrier
local
confin
virus
cell
surfac
moreov
lv
vector
transduc
nondivid
cell
airway
epithelium
slowli
magnetofect
increas
infect
compar
viru
alon
nonpolar
polar
bronchial
cell
greatli
enhanc
transduct
dome
cell
form
hemicyst
contain
fluid
resist
lentivir
transduct
ex
vivo
gene
transfer
hepatocyt
could
serv
sever
purpos
context
gene
therapi
cell
transplant
wang
et
al
demonstr
util
enhanc
transduct
primari
hepatocyt
lentivir
magnetofect
ex
vivo
similarli
naka
et
al
infect
kl
immatur
hematopoiet
stem
cell
retroviru
use
viromag
reagent
transplant
transduc
cell
intraven
lethal
irradi
mice
bone
marrow
transplant
viromag
allow
author
increas
viru
infect
concentr
viru
cell
led
breakthrough
discoveri
field
chronic
myeloid
leukemia
cml
author
show
tgfbfoxo
transcript
factor
essenti
role
mainten
leukemia
initi
cell
lic
abil
lic
caus
diseas
significantli
decreas
defici
likewis
hosokawa
et
al
use
magnetofect
boost
lentivir
infect
gene
silenc
approach
hematopoiet
stemprogenitor
cell
show
inhibit
ncadherin
express
acceler
cell
divis
vitro
reduc
lodgement
donor
hspc
endost
surfac
result
signific
reduct
longterm
engraft
find
suggest
ncadmedi
cell
adhes
function
requir
establish
hematopoiesi
bm
nich
bm
transplant
magnetofect
also
benefici
knock
laminin
ac
express
lentivir
shrna
low
moi
human
epitheli
cell
silenc
express
transcript
factor
human
hematopoiet
cell
produc
stabli
transduc
human
neuroblastoma
cell
low
viral
titer
infect
primari
mesencephal
cell
magnetofect
also
highli
use
studi
adenovir
vector
mention
special
applic
discuss
detail
magnetofect
effect
way
transfect
plasmid
dna
varieti
primari
cell
includ
primari
neuron
known
notori
difficult
transfect
sensit
toxic
cell
balanc
transfect
effici
toxic
effect
problem
biolog
electrophysiolog
studi
context
magnetofect
reagent
proven
effici
minim
undesir
secondari
effect
larg
varieti
primari
neuron
hippocamp
cortic
neocort
vagal
affer
dorsal
root
ganglion
nodos
ganglion
cerebellar
granul
motor
neuron
multipot
neural
precursorstem
cell
npc
success
transfect
high
transfect
effici
achiev
primari
rat
astrocyt
cerebr
cortic
recent
year
divya
chari
group
contribut
great
deal
methodolog
develop
magnetofect
neuron
neurogli
cell
includ
studi
use
oscil
magnet
field
furthermor
carri
studi
uptak
magnet
nanoparticl
cell
type
associ
toxic
recent
studi
gene
deliveri
multipot
neural
precursorstem
cell
npc
major
transplant
popul
key
properti
promot
repair
sever
neuropatholog
condit
demonstr
use
neurospher
cultur
model
system
even
repeat
nonvir
transfect
multifect
magnet
nanoparticl
feasibl
neglig
toxic
differenti
potenti
npc
maintain
surviv
differenti
neural
tissu
array
posttransplant
even
though
magnet
field
applic
littl
enhanc
effect
studi
find
import
view
emerg
regen
therapi
genet
modifi
cell
anoth
cell
type
interest
spinal
motor
neuron
cell
use
vitro
model
studi
basic
mechan
develop
axon
growth
gain
insight
mechan
underli
motor
neuron
diseas
far
function
studi
primari
motor
neuron
hamper
lack
effici
transfect
tool
achiev
either
protein
overexpress
gene
knockdown
transduct
lentivir
vector
current
standard
protocol
method
face
sever
limit
size
insert
cytotox
well
requir
safeti
precaut
special
equip
order
overcom
limit
fallini
et
al
establish
new
protocol
base
magnetofect
use
neuromag
reagent
optim
condit
transfect
rate
routin
achiev
alter
morpholog
surviv
transfect
motor
neuron
moreov
gene
express
observ
high
level
sever
day
transfect
cotransfect
three
differ
plasmid
gene
knockdown
use
shrna
construct
also
success
perform
author
thu
abl
show
first
time
spinal
muscular
atrophydiseas
protein
smn
activ
transport
along
axon
live
primari
neuron
support
axonspecif
role
smn
besid
involv
mrna
splice
final
motor
neuron
adapt
magnetofect
protocol
use
deliv
shrnabas
construct
therebi
significantli
reduc
smn
level
cell
bodi
axon
import
experiment
procedur
also
post
alzheim
research
forum
websit
http
wwwalzforumorgnewdetailasp
matur
cultur
neuron
magnetofect
contribut
demonstr
role
debrin
modul
glutamaterg
gabaerg
synapt
activ
specif
detail
magnetofect
protocol
cdna
shrna
vector
transfect
hippocamp
neuron
cultur
sever
hour
day
vitro
publish
also
allow
doubletransfect
longlast
dna
shrna
construct
express
without
interf
neuron
differenti
matur
neuron
sensit
commerci
lipid
reagent
exposur
immatur
neuron
lipid
exposur
time
transfectiontox
neuronscan
reduc
magnetofect
thu
sbai
et
al
associ
lipid
reagent
magnet
particl
dna
transfect
point
vesicular
traffick
secret
neuron
cell
marchionni
et
al
investig
role
gephyrin
gabaa
receptor
function
posttransl
level
use
specif
singl
chain
antibodi
fragment
gephyrin
scfvgephyrin
hamper
function
carri
studi
need
achiev
express
egfp
control
scfv
gephyrin
protein
primari
hippocamp
neuron
possibl
magnetofect
express
cultur
rat
hippocamp
neuron
fusion
protein
contain
nuclear
local
signal
scfvgephyrin
abl
remov
endogen
gephyrin
gabaa
receptor
cluster
author
shown
signific
reduct
number
synapt
contain
gabaa
receptor
signific
decreas
densiti
gabaerg
presynapt
marker
vesicular
gaba
transport
vgat
scfvgephyrin
transfect
neuron
effect
associ
reduct
amplitud
frequenc
miniatur
inhibitori
postsynapt
current
mipsc
also
signific
reduct
gabaa
receptormedi
tonic
conduct
result
indic
gephyrin
essenti
maintain
synapt
gabaa
receptor
cluster
right
posit
also
regul
phasic
tonic
inhibit
takei
also
adapt
neuromag
reagent
transfect
primari
neuron
dorsal
root
ganglion
well
neuroblastoma
cell
line
assist
show
phosphoryl
nogo
receptor
casein
kinas
ii
inhibit
bind
myelinassoci
protein
brainderiv
neurotroph
factor
stimul
phosphoryl
suppress
nogodepend
inhibit
neurit
outgrowth
neuroblastomaderiv
neural
cell
similarli
rat
adult
neuron
extracellular
treatment
overcom
inhibit
neurit
outgrowth
myelinassoci
protein
find
provid
new
strategi
control
nogo
signal
henc
neuron
regener
nogo
signal
critic
role
develop
mainten
central
nervou
system
cn
inhibit
differenti
migrat
neurit
outgrowth
neuron
caus
poor
recoveri
adult
cn
damag
summar
magnetofect
method
becom
import
tool
neurosci
research
recent
year
magnetofect
effect
way
transfect
plasmid
dna
varieti
primari
cell
primari
mous
gastric
gland
epitheli
cell
epitheli
cell
variou
tissu
retin
pigment
epithelium
human
umbil
vein
endotheli
cell
porcin
aortic
endotheli
cell
mesenter
lymph
node
endotheli
cell
ventricular
cardiomyocyt
neuron
myoblast
chondrocyt
fibroblast
synoviocyt
osteoblast
melanocyt
mous
embryon
stem
cell
spermatozoa
magnetofect
success
chen
et
al
develop
shield
magnet
peidna
formul
compris
specif
singl
chain
antibodi
ligand
cell
composit
achiev
enhanc
gene
transfer
effici
cell
line
lee
et
al
establish
protocol
magnetofect
mous
embryon
stem
cell
transfect
effici
high
compar
nonmagnet
transfect
reagent
cell
retain
es
marker
even
passag
also
retain
abil
form
embryoid
bodi
differenti
vitro
cell
three
germ
layer
impress
demonstr
potenc
ex
vivo
magnetofect
contribut
svingen
et
al
establish
new
protocol
function
studi
combin
organ
cultur
explant
fetal
tissu
microinject
magnetofect
gene
express
construct
cdna
sri
gene
shrna
construct
downregul
express
magnetofect
genit
ridg
tissu
gain
function
approach
first
case
lossoffunct
latter
case
express
sri
induc
femaletomal
sexrevers
wherea
knockdown
express
caus
maletofemal
sexrevers
consist
known
function
gene
studi
highlight
potenc
magnetofect
studi
gene
function
development
biolog
mani
studi
magnetofect
use
one
mani
methodolog
tool
requir
defin
biochem
signal
pathway
broad
varieti
research
field
exampl
basil
et
al
interest
semaphorin
famili
protein
origin
identifi
regul
axon
growth
protein
also
implic
blood
vessel
develop
use
magnetofect
research
tool
basil
et
al
abl
highlight
role
semaphorin
tumorinduc
angiogenesi
character
involv
mechan
anoth
studi
deciph
angiogen
pathway
mannel
et
al
use
magnetofect
antisens
oligonucleotid
defin
role
tyrosin
phosphatas
angiogenesi
anoth
studi
relev
identifi
mechan
cancer
develop
steel
et
al
use
magnetofect
gastric
epitheli
cell
identifi
promot
element
regul
express
put
growth
factor
significantli
increas
helicobact
pylori
infect
patient
h
pylori
acceler
progress
gastric
cancer
unknown
mechan
use
magnetofect
research
tool
steel
et
al
could
demonstr
role
promot
element
respond
h
pylori
gastrin
themat
relat
studi
also
involv
magnetofect
ashurst
et
al
defin
minim
promot
requir
transcript
human
gastric
adenocarcinoma
gastrincck
receptor
play
major
role
physiolog
regul
gastric
acid
secret
magnetofect
also
help
establish
model
identifi
mechan
infect
viral
pathogen
exampl
mitsutani
et
al
use
magnetofect
examin
pathway
involv
sarscoronaviru
infect
sarscov
caus
sever
acut
respiratori
syndrom
sar
guix
et
al
use
magnetofect
establish
model
norwalk
viru
nv
infect
norwalk
virus
nv
positivesens
rna
virus
lead
caus
epidem
acut
viral
gastroenter
develop
countri
absenc
vitro
cell
cultur
model
nv
infect
hamper
develop
effect
antivir
therapi
vaccin
use
magnetofect
author
abl
transfect
cell
nv
rna
isol
stool
sampl
human
volunt
transfect
lead
viral
replic
express
viral
antigen
rna
replic
releas
viral
particl
medium
therefor
demonstr
first
time
nv
rna
isol
stool
sampl
human
volunt
infecti
transfect
mammalian
cell
magnetofect
dna
use
numer
mechanist
studi
establish
model
system
requir
ongo
research
cours
dna
transfect
numer
cell
line
also
demonstr
effici
sirna
deliveri
mediat
magnetofect
report
numer
cell
line
monkey
kidney
rat
fibroblast
vero
cell
monkey
kidney
integrin
normal
rat
intestin
epitheli
cell
line
cell
hela
cell
human
microvascular
endotheli
cell
sever
report
sirna
deliveri
magnet
nanoparticl
vivo
publish
recent
discuss
cell
cultur
model
intend
better
mimic
situat
intact
tissu
vivo
zhang
et
al
demonstr
report
gene
sirna
deliveri
collagengel
matrix
cell
cultur
driven
extern
magnet
field
purpos
prepar
peicoat
magnet
nanoparticl
ligand
exchang
reaction
nm
oleic
acidco
particl
complex
dna
sirna
prepar
particl
penetr
cultur
magnet
field
influenc
highli
effici
nucleic
acid
deliveri
nonmagnet
complex
ineffici
encourag
tissu
penetr
one
limit
factor
nucleic
acid
deliveri
vivo
review
paper
bonetta
et
al
evalu
gene
deliveri
method
highlight
potenti
magnetofect
tool
improv
target
broader
rang
cell
applic
way
benefit
use
magnetofect
concentr
promot
effici
sirna
transfect
assess
publish
comprehens
review
protocol
sirna
magnetofect
recent
sever
excel
nonmagnet
reagent
sirna
transfect
commerci
avail
similarli
dna
transfect
true
benefit
magnetofect
becom
evid
difficult
transfect
primari
cell
would
like
discuss
recent
applic
primari
cell
instead
repeat
publish
elsewher
magnetofect
shown
effect
way
transfect
sirna
human
primari
endotheli
cell
deriv
umbil
vein
human
cord
blood
contribut
demonstr
critic
role
transcript
factor
angiogenesi
select
estrogen
receptor
modul
atherosclerosi
similarli
magnetofectioninduc
gene
knockdown
sirna
allow
research
figur
implic
certain
kinas
rockii
isoform
format
microparticl
respons
thrombin
stimul
magnetofect
nm
sirna
induc
inhibit
two
isoform
rho
kinas
ii
specif
target
rockii
sirna
one
implic
releas
endotheli
microparticl
respons
thrombin
stimul
unravel
new
pathway
microparticl
format
three
year
later
author
continu
studi
releas
procoagul
endotheli
microparticl
induc
thrombin
use
silencemag
magnetofect
reagent
primari
human
umbil
vein
endotheli
cell
huvec
transfect
endotheli
cell
sirna
target
trail
induc
decreas
microparticl
product
respons
thrombin
moreov
reduc
procoagul
potenti
endotheli
microparticl
unravel
potenti
mechan
link
inflamm
coagul
also
meda
et
al
use
sirna
magnetofect
huvec
examin
biphas
effect
drug
nitric
oxid
bioavail
cytotox
well
drug
interfer
interact
endotheli
synthas
eno
ge
et
al
use
magnetofect
sirna
deliveri
human
pulmonari
arteri
endotheli
cell
elucid
pathway
angiotensin
iimedi
vascular
inflamm
earli
event
leukocyt
adhes
endothelium
essenti
event
inflamm
requir
pselectin
surfac
express
turn
probabl
requir
releas
pselectin
intracellular
store
via
exocytosi
use
sirna
magnetofect
knock
two
particular
kinas
ge
et
al
could
pinpoint
molecular
link
trigger
exocytosi
angiotensin
ii
consequ
pselectin
surfac
express
henc
abl
propos
mechan
link
angiotensin
ii
signal
inflamm
primari
human
gastric
myofibroblast
also
difficult
transfect
mccaig
et
al
use
magnetofect
deliv
sirna
primari
human
gastric
myofibroblast
deciph
role
redefin
gastric
environ
respons
bacteria
team
use
sirna
magnetofect
silenc
upar
express
primari
gastric
gland
epitheli
cell
show
upar
knockdown
significantli
inhibit
h
pyloriinduc
prolifer
find
high
import
h
pylori
induct
upa
lead
epitheli
prolifer
inhibit
upa
action
may
slow
progress
gastric
cancer
anoth
challeng
cell
type
primari
dendrit
cell
success
magnetofect
sirna
dendrit
cell
dc
profession
antigen
present
cell
critic
host
immun
induc
specif
immun
respons
broad
varieti
pathogen
use
sirna
magnetofect
primari
dc
melki
et
al
reveal
dc
infect
becom
resist
kill
natur
killer
nk
cell
protect
nk
cytotox
induc
crosstalk
result
upregul
two
celldeath
inhibitor
magnetofect
sirna
perform
studi
loss
function
two
apoptosi
inhibitor
magnetofect
also
report
effect
sirna
transfect
suspens
cell
jurkat
human
cell
leukemia
permit
show
implic
receptorbind
cancer
antigen
cell
apoptosi
induc
hiv
infect
rtpcr
analysi
confirm
reduc
mrna
express
cell
allow
author
show
apoptosi
induc
hivtat
block
inhibit
small
interf
rna
specif
thu
demonstr
effect
receptorbind
cancer
antigen
tatinduc
apoptosi
author
deciph
one
mechan
induc
death
cell
infect
uchida
et
al
tan
et
al
succeed
deliv
sirna
primari
rat
embryon
drg
neuron
primari
cortic
neuron
de
lartigu
et
al
investig
role
satieti
peptid
cartp
knock
express
rat
primari
vagal
affer
neuron
cell
magnetofect
use
nm
sirna
experi
perform
h
transfect
data
provid
direct
evid
autocrineposit
feedback
mechan
cart
involv
appear
play
role
preexist
stock
releas
act
secret
provid
illustr
mechan
previous
receiv
detail
consider
rais
possibl
develop
novel
therapi
base
augment
prolong
action
establish
gutbrain
signal
molecul
use
transfect
protocol
nm
sirna
direct
earli
growth
respons
factor
author
found
potenti
therapeut
interest
factor
posttranscript
gene
silenc
use
sirna
silencemag
appli
examin
specif
role
inositol
triphosph
receptor
receptor
channel
arginin
vasopressin
activ
smooth
muscl
cell
nm
sirna
mix
silencemag
sirna
transfect
reagent
silenc
receptor
receptor
channel
gene
express
cell
result
present
li
et
al
show
import
receptor
receptor
channel
calcium
signal
moreov
whole
paper
li
et
al
dedic
evalu
sirna
model
system
smooth
muscl
cell
primari
mous
myoblast
silencemag
combimag
magnetofect
reagent
use
studi
express
intracellular
local
vesicl
associ
membran
protein
transfect
sirna
target
perform
day
differenti
base
result
author
propos
protein
could
use
molecular
marker
quiescent
satellit
cell
myotub
recent
silencemag
use
transport
sirna
osteoblast
cell
zhang
et
al
model
develop
author
first
transform
cell
use
nm
sirna
silencemag
silenc
express
treatment
result
condit
medium
use
stimul
osteoclast
cell
shown
less
effect
induc
osteoclast
marker
cathepsin
k
protein
author
conclud
key
role
play
secret
regul
bone
metabol
one
highlight
recent
literatur
paper
namiki
et
al
sirna
deliveri
tumor
mous
model
discuss
detail
place
would
like
mention
work
namiki
colleagu
possibl
comprehens
studi
develop
magnet
target
sirna
deliveri
system
far
cover
everyth
develop
lipidmagnet
sirna
formul
success
applic
vivo
carri
comprehens
screen
construct
differ
cell
line
proceed
vivo
experi
lead
us
next
chapter
summar
magnetofect
becom
import
tool
gene
silenc
upon
transfect
exogen
sirna
numer
discoveri
biolog
mechan
made
difficult
transfect
cell
apart
commerci
avail
reagent
sirna
magnetofect
sever
research
group
develop
magnet
nanoparticl
formul
sirna
deliveri
highli
effici
gene
silenc
report
nucleic
acid
deliveri
magnet
nanoparticl
vivo
less
abund
numer
public
cell
cultur
applic
substanti
bodi
literatur
accumul
last
year
public
summar
tabl
system
administr
via
circul
challeng
drug
deliveri
system
magnet
nonmagnet
magnet
composit
assembl
noncoval
interact
dissoci
assembl
vivo
milieu
occur
thu
obviat
magnet
target
furthermor
vertebr
equip
defens
mechan
elimin
intrud
virus
bacteria
unfortun
nanomedicin
complement
system
phylogenet
ancient
form
innat
immun
tag
intrud
elimin
circul
macrophag
recogn
challeng
construct
gene
vector
mani
year
ago
remain
challeng
particul
drug
deliveri
system
gener
commonli
use
approach
protect
drug
deliveri
system
undesir
interact
blood
compon
rapid
elimin
circul
reticuloendotheli
system
re
surfac
shield
polym
like
polyethylenglycol
highli
effect
establish
liposom
mani
year
ago
concept
implement
multicompon
magnet
composit
nucleic
acid
deliveri
recent
suffici
long
circul
bloodstream
least
ten
minut
better
hour
timescal
prerequisit
captur
substanti
fraction
magnet
drug
formul
target
tissu
first
pass
retent
magnet
gradient
field
low
except
low
blood
flow
rate
first
passag
drug
carrier
distribut
throughout
vascular
system
system
drug
deliveri
tumor
longcircul
drug
formul
extravas
tumor
tissu
enhanc
permeabl
retent
effect
epr
effect
effect
design
increas
leaki
blood
vessel
tumor
tissu
compar
normal
tissu
current
strategi
system
gene
drug
deliveri
tumor
aim
combin
passiv
target
via
epr
effect
activ
target
exploit
magnet
forc
biolog
receptorligand
interact
among
publish
tabl
select
report
nucleic
acid
deliveri
magnet
nanoparticl
vivo
studi
sever
focus
system
deliveri
nucleic
acid
magnetofect
cell
tumor
use
magnet
carrier
surprisingli
two
studi
magnet
field
appli
enhanc
accumul
magnet
cell
nucleic
acid
carrier
respect
tumor
tissu
although
earlier
report
magnet
target
nucleic
acid
deliveri
vivo
breakthrough
magnet
target
tumor
upon
intraven
administr
lack
namiki
et
al
publish
work
shown
first
time
concept
feasibl
also
demonstr
therapeut
benefit
mous
model
gastric
cancer
magnet
target
sirna
studi
japanes
author
highlight
level
interdisciplinar
requir
achiev
technolog
breakthrough
first
synthes
magnet
nanoparticl
follow
known
approach
howev
neglect
group
work
magnet
guid
nucleic
acid
deliveri
possibl
key
obtain
nanomagnet
composit
nucleic
acid
enabl
magnet
target
tumor
upon
intraven
administr
formul
result
comprehens
biophys
character
optim
involv
nucleic
acid
deliveri
studi
differ
cell
line
target
tumor
gastric
cancer
mous
model
achiev
optim
composit
magnet
field
appli
tumor
without
magnet
field
also
commerci
avail
magnet
transfect
reagent
deliveri
local
tumor
blood
vessel
consequ
author
chose
sirna
therapeut
agent
epiderm
growth
factor
receptor
egfr
express
molecular
target
egfr
overexpress
tumor
blood
vessel
endothelium
shown
valid
target
therapeut
intervent
mani
author
manner
achiev
retard
tumor
growth
clearli
link
targetspecif
action
sirna
molecular
level
advers
reaction
one
might
expect
deliveri
magnet
nanoparticl
egfr
knockdown
nontarget
organ
observ
namiki
colleagu
first
demonstr
target
nucleic
acid
specif
sirna
tumor
demonstr
associ
therapeut
benefit
use
differ
tumor
model
huang
colleagu
achiev
even
favor
sirna
biodistribut
profil
nonmagnet
shield
receptortarget
formul
research
use
nonmagnet
receptortarget
gene
deliveri
even
report
complet
tumor
remiss
nevertheless
studi
namiki
colleagu
open
new
perspect
show
accumul
tumor
therapeut
benefit
nonshield
nonreceptor
target
formul
sirna
enabl
magnet
forc
magnet
target
enforc
first
essenti
step
nucleic
acid
deliveri
accumul
target
tissu
establish
target
cell
contact
henc
one
expect
futur
combin
shield
receptor
target
magnet
target
result
synergist
improv
doserespons
profil
limit
medic
point
view
magnet
drug
target
make
sens
primarili
local
stage
diseas
less
metastat
stage
drug
action
may
requir
throughout
bodi
nevertheless
plenti
medic
indic
magnet
target
nucleic
acid
may
yield
substanti
advantag
major
limit
magnet
drug
target
physic
one
magnet
forc
act
magnet
nanoparticl
drop
power
distanc
sourc
magnet
field
depend
geometri
pole
shoe
penetr
depth
forc
proport
magnet
flux
densiti
field
gradient
low
trivial
gener
suffici
field
gradient
target
site
insid
bodi
supplementari
materi
paper
namiki
colleagu
describ
biocompat
surfac
coat
perman
magnet
titanium
nitrid
minimalinvas
implant
magnet
tumor
site
may
provid
viabl
solut
gener
suffici
magnet
forc
magnet
drug
target
among
public
system
nucleic
acid
deliveri
tumor
nanomagnet
carrier
work
medarova
colleagu
inspir
base
earlier
work
josephson
et
al
prepar
dextranco
magnet
nanoparticl
coval
attach
sirna
nearinfrar
dye
membran
transloc
peptid
use
magnet
reson
optic
imag
shown
feasibl
vivo
track
tumor
uptak
carrier
furthermor
use
optic
imag
could
follow
silenc
target
report
gene
vivo
concept
use
therapeut
relev
sirna
receptor
target
system
could
demonstr
favor
accumul
system
therapeut
benefit
human
breast
adenocarcinoma
xenograft
model
nude
mice
remark
achiev
without
appli
magnet
target
would
interest
know
whether
would
yield
addit
benefit
conceptu
relat
work
publish
kievit
veiseh
colleagu
develop
nanovector
consist
iron
oxid
core
coat
copolym
chitosan
polyethylen
glycol
peg
poli
ethylen
imin
pei
electrostat
bind
plasmid
dna
encod
gene
interest
sirna
chlorotoxin
ctx
receptor
ligand
attach
system
use
short
peg
linker
upon
intraven
inject
achiev
effici
gene
deliveri
rat
glioma
xenograft
tumor
nude
mice
author
appli
magnet
target
argu
strategi
provid
littl
advantag
highli
invas
infiltr
cancer
glioma
previou
studi
group
shown
similar
magnet
nanoparticl
conjug
without
pei
nucleic
acid
equip
nearinfrar
dye
accumul
well
autochthon
medulloblastoma
tumor
genet
engin
mice
case
system
use
multimod
imag
probe
nucleic
acid
deliveri
work
magnet
target
nucleic
acid
upon
system
administr
includ
earli
proof
principl
experi
magnet
local
dna
oligonucleotid
deliveri
vascular
system
interest
find
ion
oxid
nanoparticl
obtain
xiang
et
al
claim
intraven
inject
polylysineco
iron
oxid
nanoparticl
even
transfer
dna
across
bloodbrain
barrier
glial
cell
neuron
brain
magnet
target
involv
studi
major
report
gene
express
found
mous
lung
vector
composit
use
later
li
et
al
deliveri
antimetastat
gene
pulmonari
metastasi
mous
model
therapeut
benefit
could
achiev
tumor
growth
inhibit
also
magnet
target
involv
magnet
target
involv
howev
studi
publish
steinhoff
group
achiev
magnet
target
gene
deliveri
cardiac
tissu
magnet
carrier
assembl
biotinyl
peidna
complex
streptavinco
magnet
nanoparticl
cell
express
report
gene
identifi
endotheli
cell
histolog
analysi
manner
author
achiev
magnet
target
deliveri
therapeut
relev
vegf
gene
flexman
et
al
achiev
magnet
accumul
feridex
mri
contrast
agent
head
rat
purpos
contrast
agent
incorpor
hemagglutin
viru
japan
envelop
hvje
nucleic
acid
deliveri
involv
studi
mention
mani
previou
studi
hvje
shown
excel
agent
gene
deliveri
muthana
et
al
accumul
magnetofect
monocyt
prostat
cancer
cell
line
tumor
xenograft
nude
mice
upon
intraven
administr
relev
applic
genet
engin
cell
consid
use
indirect
gene
deliveri
agent
tumor
cheong
et
al
describ
water
solubl
chitosanlinol
acid
conjug
use
assembl
complex
dna
sirna
magnet
nanoparticl
complex
inject
intraven
mice
accumul
passiv
liver
gave
rise
report
gene
express
magnet
target
involv
studi
contrast
zheng
et
al
appli
magnet
target
liver
upon
intraven
inject
magnet
composit
dna
rat
observ
increas
report
gene
express
organ
compar
absenc
magnet
target
hofmann
et
al
prepar
magnet
lentivir
vector
electrostat
interact
commerci
avail
combimag
transmag
magnet
particl
use
vector
demonstr
magnet
local
transduct
physiolog
flow
condit
explant
aorta
next
step
inject
vector
carotid
arteri
mice
perman
magnet
place
right
abdomin
wall
close
liver
signific
redistribut
lvmnp
complex
liver
observ
concomitantli
number
viral
integr
lung
significantli
reduc
author
also
show
huvec
magnetofect
high
magnet
nanoparticl
dose
could
magnet
posit
blood
vessel
wall
ex
vivo
model
final
show
well
possibl
vivo
upon
inject
thorac
aorta
lentivir
magnetofect
cell
accumul
abdomin
aorta
iliac
arteri
area
magnet
field
influenc
similarli
author
could
magnet
target
cell
denud
common
carotid
arteri
upon
inject
carotid
arteri
studi
relev
field
stem
cell
transplant
tissu
repair
tissu
engin
genet
modifi
cell
also
respect
target
genet
modifi
cell
tumor
summar
major
progress
made
magnet
target
upon
system
administr
time
clear
essenti
progress
requir
respect
longcircul
magnet
formul
clearcut
preferenti
accumul
magnet
composit
magnet
target
tissu
public
cite
includ
lack
detail
biodistribut
studi
absolut
requir
demonstr
benefit
magnet
target
curiou
note
mani
author
cite
abstain
magnet
target
even
though
use
nanomagnet
carrier
rais
question
whether
magnet
target
work
yield
addit
advantag
studi
contrast
system
applic
local
administr
target
tissu
vivo
technic
simpl
earli
work
demonstr
magnet
target
function
nonvir
gene
deliveri
ileum
lumen
rat
laparatomi
stomach
mice
magnet
particleadenoviru
composit
report
gene
transfer
strongli
enhanc
area
influenc
magnet
field
wherea
without
applic
magnet
control
either
much
poorer
transfectiontransduct
achiev
howev
author
find
enhanc
magnet
field
applic
local
inject
magnet
vector
case
xenari
studi
nonvir
gene
transfer
murin
nasal
epithelium
morishita
et
al
experi
directli
inject
maghemit
nanoparticl
associ
hvje
vector
liver
mice
studi
magnet
nanoparticl
alon
without
magnet
field
applic
suffici
yield
enhanc
gene
transfer
galuppo
et
al
found
littl
function
gene
deliveri
synovi
membran
upon
intraarticular
inject
report
dna
complex
peicoat
magnet
nanoparticl
sheep
independ
magnet
field
applic
howev
studi
yield
insight
toler
composit
vivo
agraw
et
al
achiev
effici
deliveri
sirna
associ
magnet
dendriworm
vitro
vivo
appli
magnet
field
studi
local
applic
vivo
intracrani
convectionenhanc
deliveri
mous
brain
dendriworm
sirna
direct
epiderm
growth
factor
receptor
egfr
led
specif
signific
suppress
egfr
express
set
similarli
han
et
al
use
bacteri
magnet
nanoparticl
bmp
conjug
pamam
dendrim
tat
peptid
carrier
small
interf
rna
express
plasmid
psirna
downregul
egfr
express
human
glioblastoma
cell
vitro
vivo
appli
magnetofect
condit
magnet
field
vitro
subcutan
tumor
model
vivo
upon
intratumor
inject
magnet
composit
achiev
tumor
growth
retard
signific
differ
mice
treat
nonmagnet
lipofectamin
treatment
group
true
magnetofect
condit
appli
song
recent
studi
gene
deliveri
variou
glioma
cell
line
neural
stem
cell
astrocytoma
cell
line
vitro
upon
intrathec
inject
lumbar
spinal
cord
subarachnoid
space
rat
magnet
carrier
plasmid
dna
use
commerci
avail
polymag
transfect
reagent
conjunct
bi
cysteinyl
histidinerich
endosomolyt
tat
peptid
enhanc
transfect
effici
vivo
experi
place
magnet
back
anim
order
prevent
gene
transfer
complex
carri
away
cerebrospin
fluid
flow
examin
two
condit
one
magnet
remain
static
one
magnet
move
along
spinal
cord
latter
condit
peak
level
report
gene
express
detect
cervic
spinal
cord
remot
inject
site
lowest
level
transgen
express
lumbar
spinal
cord
henc
author
demonstr
model
magnet
vector
magnet
guid
local
inject
similar
find
report
hashimoto
et
al
attach
adenovir
gene
vector
magnet
particl
via
biotinstreptavidin
linkag
manner
could
direct
adenovir
gene
deliveri
restrict
region
mous
brain
magnet
forc
magnetofect
includ
magnet
field
applic
yield
clear
advantag
magnet
vaccin
studi
zhou
et
al
xiang
et
al
zhou
colleagu
inject
magnet
dna
report
gene
composit
tibiali
anterior
ta
muscl
mice
rabbit
found
clearli
enhanc
report
gene
express
magnet
field
influenc
compar
control
nake
dna
magnet
vector
absenc
magnet
field
assess
rel
abil
prime
antibodi
tcell
respons
mice
immun
intramuscular
inject
gag
dna
magnet
vector
magnetofect
condit
magnet
vector
without
magnet
field
applic
nake
dna
magnetofect
significantli
enhanc
antibodi
respons
gag
protein
compar
control
furthermor
magnetofect
induc
immun
respons
much
lower
dna
dose
nake
dna
indic
approxim
increas
dna
vaccin
potenc
furthermor
magnetofect
acceler
develop
humor
immun
respons
significantli
magnetofect
gave
seroconvers
alreadi
week
singl
immun
compar
week
nake
dna
major
clinic
interest
zhou
et
al
also
examin
cytotox
tlymphocyt
ctl
respons
induc
immun
magnet
dna
vaccin
also
respect
magnetofect
display
increas
dna
vaccin
potenc
term
requir
dna
dose
author
specul
observ
enhanc
may
base
improv
tissu
penetr
vaccin
magnetofect
condit
transient
tissu
damag
magnet
vaccin
possibl
transfect
profession
antigen
present
cell
apc
xiang
et
al
obtain
similar
result
magnet
dna
vaccin
base
peicoat
bacteri
magnet
nanoparticl
immun
mice
intramuscular
inject
magnet
nonmagnet
peidna
complex
encod
footmouth
diseas
viral
capsul
protein
also
found
signific
enhanc
humor
cellular
immun
respons
target
antigen
compar
control
magnet
dna
complex
absenc
magnet
field
nonmagnet
peidna
nake
dna
well
pei
magnet
particl
without
dna
two
studi
demonstr
substanti
potenti
magnetofect
genet
vaccin
special
type
local
administr
magnet
target
publish
dame
et
al
experi
magnet
aerosol
call
nanomagnetosol
magnet
aerosol
gener
aqueou
suspens
magnet
nanoparticl
use
nebul
case
nebul
approv
inhal
therapi
nanomagnetosol
liquid
droplet
compris
magnet
fig
treatment
felin
fibrosarcoma
studi
magnet
dna
composit
inject
directli
tumor
magnet
field
hold
particl
tumor
uptak
tumor
cell
express
dna
sequenc
lead
product
messeng
substanc
activ
anim
immun
system
success
excis
tumor
isol
malign
cell
still
remain
cat
bodi
immun
system
appar
better
equip
deal
incid
recurr
dramat
decreas
imag
show
treatment
clinic
imag
left
show
rel
larg
recurr
tumor
reappear
soon
surgic
excis
origin
tumor
surgic
scar
initi
treatment
still
visibl
imag
show
felovectin
treatment
anoth
anim
direct
inject
tumor
follow
fixat
small
perman
magnet
cm
h
surfac
tumor
magnet
field
hold
inject
substanc
tumor
trigger
uptak
tumor
cell
nanoparticl
addit
compris
activ
ingredi
gene
vector
use
electromagnet
dame
et
al
could
target
dna
deliveri
specif
region
mous
lung
respect
lung
diseas
aerosol
deliveri
drug
inhal
repres
straightforward
strategi
target
diseas
tissu
previou
studi
approach
target
dose
intensif
attempt
human
lung
cancer
therapi
respect
physic
constraint
magnet
drug
target
import
featur
nanomagnetosol
fact
case
aerosol
actual
drug
carrier
aerosol
droplet
sever
micromet
diamet
compris
multitud
magnet
nanoparticl
henc
carrier
appear
extern
magnet
field
like
one
larg
magnet
particl
anoth
compel
featur
magnet
aerosol
activ
ingredi
need
bound
magnet
particl
requir
compris
within
aerosol
droplet
magnet
aerosol
use
tool
increas
deposit
dose
drug
lung
direct
preferenti
one
lung
lobe
ongo
experi
technolog
evalu
pig
preliminari
result
confirm
magnet
target
also
larger
dimens
unpublish
result
studi
therapeut
applic
magnetofect
focus
immunogen
therapi
felin
fibrosarcoma
fig
one
frequent
tumor
diseas
cat
extrem
high
recurr
rate
anim
tumor
recur
within
year
surgic
remov
ongo
veterinari
clinic
studi
inject
plasmid
dna
compris
cytokin
gene
electrostat
bound
positivelycharg
magnet
nanoparticl
directli
tumor
call
composit
magnetovax
subsequ
perman
magnet
attach
tumor
adhes
tape
order
hold
inject
dose
tumor
may
also
enhanc
uptak
magnet
complex
tumor
cell
inject
carri
week
week
prior
surgic
remov
tumor
standard
therapi
shown
treatment
actual
lead
express
therapeut
gene
cytokin
intend
activ
immun
system
tumor
suffici
manner
control
remain
tumor
cell
surgeri
meantim
anim
patient
treat
variou
treatment
arm
studi
treatment
well
toler
treatment
drastic
increas
percentag
longterm
relapsefre
anim
result
studi
publish
soon
conclud
review
paper
would
like
discuss
recent
develop
one
magnet
oncolyt
adenoviru
demonstr
enhanc
infect
cell
kill
potenc
promis
anticanc
agent
tumor
cell
resist
adenovir
infect
anoth
magnet
microbubbl
combin
magnet
target
ultrasound
mediat
deliveri
nucleic
acid
third
magnet
cell
separ
magnetofect
combin
one
integr
procedur
tool
futur
cell
therapi
implement
cell
therapi
approach
requir
effici
method
separ
genet
modif
cell
costeffect
manner
low
vector
consumpt
minimum
number
handl
step
amen
autom
close
system
develop
new
methodolog
cell
separ
transfect
transduct
singl
standard
procedur
call
magselectofect
present
schemat
fig
high
gradient
magnet
field
cell
separ
column
use
magnet
devic
associ
magnet
gene
deliveri
vector
magnet
label
cell
passag
separ
column
model
cell
mixtur
suspens
jurkat
cell
demonstr
optim
load
separ
column
magnet
vector
interfer
cell
separ
effici
genet
modif
occur
predominantli
target
cell
popul
nonvir
viral
magnet
vector
optim
magnet
vector
formul
allow
almost
complet
vector
immobil
associ
target
cell
column
stronger
magnet
forc
prevail
high
gradient
field
magnet
separ
column
also
high
concentr
reactant
vector
cell
magselectofect
condit
enforc
vectortarget
cell
contact
enhanc
intern
vector
result
highli
effici
transfect
transduct
cell
line
primari
monocel
cultur
human
umbil
cord
mesenchym
cell
appli
pg
plasmid
dna
per
cell
cell
transfect
cell
transduc
depend
donor
use
transduc
unit
lentiviru
per
cell
report
gene
express
stabli
maintain
month
donor
lentivir
moi
low
cell
densiti
cell
transduc
egfp
report
maintain
progenitor
cell
phenotyp
magselectofect
lentivir
magselectofect
low
moi
yield
transduc
mous
lin
cell
persist
reconstitut
b
cell
mice
compar
less
higher
moi
use
standard
transduct
protocol
lin
bone
marrow
cell
develop
technolog
becom
valuabl
tool
cell
therapi
genet
engin
cell
despit
mani
report
magnet
enhanc
infect
littl
known
whether
concept
use
enhanc
oncolyt
potenc
replic
virus
oncolyt
virus
count
among
promis
innov
cancer
therapeut
therefor
examin
potenti
boost
efficaci
oncolyt
adenoviru
associ
magnet
nanoparticl
magneticfieldguid
infect
multidrugresist
mdr
cardefici
tumor
cancer
cell
vitro
upon
intratumor
inject
vivo
characterist
morpholog
complex
nanoparticl
given
tabl
c
f
ultrasound
magnet
field
fig
respect
viral
uptak
cell
optim
magnet
viru
complex
given
viru
dose
enhanc
compar
nonmagnet
viru
infect
carri
influenc
magnet
field
fig
increas
viru
intern
result
enhanc
oncolyt
potenc
term
dose
requir
kill
target
cell
ic
valu
fig
enhanc
order
magnitud
viru
progeni
format
equal
input
viru
dose
compar
nonmagnet
virus
observ
viru
uptak
independ
car
express
cell
full
oncolyt
effect
develop
fast
within
day
postinfect
compar
day
nonmagnet
viru
refer
plot
target
cell
viabil
versu
intern
viru
particl
magnet
nonmagnet
viru
show
inher
oncolyt
product
viru
remain
unchang
upon
associ
magnet
nanoparticl
fig
henc
conclud
mechan
boost
oncolyt
effect
magnet
forc
mainli
due
improv
intern
magnet
viru
complex
result
potenti
viru
progeni
format
upon
intratumor
inject
applic
gradient
magnet
field
murin
xenograft
model
pilot
experi
magnet
viru
complex
exhibit
stronger
oncolyt
effect
adenoviru
alon
propos
approach
would
use
vivo
administr
tumorfeed
blood
vessel
boost
efficaci
primari
infect
cycl
within
tumor
system
applic
modif
magnet
adenoviru
complex
shield
retarget
whole
magnet
viru
complex
entiti
need
feasibl
efficaci
magnet
drug
target
particularli
upon
system
administr
limit
two
constraint
one
rapid
clearanc
particul
drug
carrier
circul
discuss
difficulti
exert
suffici
magnet
forc
nanomagnet
carrier
counterbal
hydrodynam
forc
blood
stream
underli
physic
discuss
excel
paper
elsewher
object
optim
retent
tissu
penetr
cellular
uptak
magnet
forc
act
magnet
drug
carrier
proport
magnet
flux
densiti
field
gradient
third
power
radiu
hydrodynam
forc
act
carrier
accord
stoke
law
proport
first
power
radiu
base
simplifi
consider
one
predict
increas
particl
size
overproport
favor
magnet
forc
hand
constraint
suitabl
particl
size
vivo
applic
given
diamet
blood
capillari
around
embol
need
avoid
therefor
magnet
formul
requir
appear
larg
diamet
magnet
particl
magnet
field
howev
small
enough
inher
flexibl
travel
blood
capillari
like
blood
cell
requir
fulfil
magnet
liposom
anoth
approach
combin
sonopor
magnetofect
microbubbl
ga
bubbl
usual
micromet
diamet
surround
shell
consist
protein
polym
lipid
combin
thereof
due
ga
content
excel
reflector
ultrasound
consequ
use
contrast
agent
medic
ultrasound
imag
low
molecular
weight
drug
nucleic
acid
associ
microbubbl
variou
way
addit
microbubbl
target
exploit
receptorligand
type
interact
includ
antigenantibodi
interact
drugload
microbubbl
hold
potenti
magic
bullet
agent
deliv
drug
precis
locat
bodi
precis
locat
determin
ultrasound
energi
focus
interact
microbubbl
ultrasound
low
mhz
rang
lead
cavit
microstream
eventu
bubbl
burst
consequ
drug
releas
addit
cavit
lead
microvessel
ruptur
lead
increas
permeabl
endotheli
barrier
effect
use
deliv
nanoparticl
even
red
blood
cell
interstitium
rat
skelet
muscl
cavit
nuclei
form
microbubbl
also
use
permeabil
bloodbrain
barrier
essenti
combin
magnetofect
microbubbl
use
success
nucleic
acid
deliveri
varieti
tissu
base
state
art
other
reason
microbubbl
may
ideal
carrier
incorpor
high
quantiti
magnet
nanoparticl
well
activ
agent
drug
nucleic
acid
fig
idea
alreadi
publish
year
soetanto
cowork
expect
flexibl
carrier
suffici
squeez
blood
capillari
magnet
accumul
carrier
hydrodynam
forc
ought
facilit
compar
free
physic
uncoupl
magnet
nanoparticl
confirm
seri
vitro
vivo
experi
publish
recent
develop
two
gener
magnet
microbubbl
first
gener
call
magnet
acoust
activ
lipospher
maal
base
composit
develop
unger
et
al
deliveri
hydrophob
drug
fig
main
compon
soybean
oil
stabil
outer
layer
amphipath
lipid
order
bind
nucleic
acid
includ
cation
lipid
transfect
reagent
formul
make
magnet
incorpor
detergentco
magnet
nanoparticl
formul
high
bind
capac
nucleic
acid
favor
magnet
properti
respons
ultrasound
cell
cultur
ultrasound
applic
enhanc
effect
gene
sirna
deliveri
magnet
field
applic
alon
howev
preclin
model
ischem
skin
flap
surviv
rat
relev
reconstruct
surgeri
best
therapeut
effect
vegfgeneload
maal
achiev
combin
applic
magnet
field
ultrasound
particular
model
maal
inject
subcutan
skin
flap
area
express
vegf
gene
lead
format
new
blood
vessel
improv
blood
suppli
tissu
anoth
model
dorsal
skinfold
chamber
model
mice
nucleic
acid
deposit
target
area
upon
inject
blood
circul
achiev
magnet
field
ultrasound
appli
combin
fig
stride
et
al
report
magnet
microbubbl
composit
highli
respons
ultrasound
achiev
signific
enhanc
gene
transfer
effici
cell
cultur
combin
applic
ultrasound
magnet
field
second
gener
magnet
microbubbl
appear
similar
properti
highli
respons
ultrasound
give
excel
contrast
ultrasound
imag
summar
magnet
microbubbl
promis
carrier
local
nucleic
acid
deliveri
clearli
studi
requir
optim
system
nevertheless
one
alreadi
state
magnet
microbubbl
use
combin
drug
deliveri
ultrasound
magnet
reson
imag
major
progress
made
field
last
year
reflect
exponenti
grow
number
public
commerci
avail
magnetofect
becom
wide
use
research
tool
applic
virtual
type
nucleic
acid
kind
nonvir
viral
gene
vector
improv
efficaci
gene
deliveri
mani
applic
benefit
potenti
magnetofect
highlight
comprehens
time
acknowledg
method
solut
limit
nucleic
acid
deliveri
mani
year
research
convent
form
deliveri
advanc
success
clinic
trial
form
target
physic
method
deliveri
highli
promis
date
side
side
comparison
combin
exampl
electropor
sonopor
hydropor
aerosol
ballist
method
occlus
blood
outflow
target
organ
biolog
target
still
rare
absenc
evid
name
method
need
consid
promis
magnetofect
electropor
probabl
advanc
method
effici
method
vitro
vivo
particularli
nondivid
cell
still
need
achiev
magnetofect
compar
physic
method
major
advantag
magnetofect
abl
combin
simplic
nonexpens
local
deliveri
enhanc
effici
reduct
incub
time
vector
dose
cite
true
potenti
method
possibl
amen
innov
integr
technolog
exampl
combin
magnet
cell
separ
nucleic
acid
deliveri
futur
cell
therapi
magnet
posit
genet
engin
cell
tissu
regener
tissu
engin
theranost
system
integr
nucleic
acid
deliveri
multimod
medic
imag
plenti
work
done
year
come
